Selective degradation of platelet BTK by PROTAC NX-5948 provides antithrombotic benefits without affecting haemostasis (2025)
Attributed to:
PROTACs as a novel Approach to target Protein Tyrosine Kinases for degradation in human Platelets
funded by
BBSRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.64898/2025.12.02.691893
Publication URI: http://dx.doi.org/10.64898/2025.12.02.691893
Type: Preprint